121 related articles for article (PubMed ID: 9577744)
21. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
Jensen ML; Dybdahl H; Svanholm H
Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
[TBL] [Abstract][Full Text] [Related]
22. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
Dalla Palma P
Cytopathology; 1997 Jun; 8(3):210. PubMed ID: 9202897
[No Abstract] [Full Text] [Related]
23. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
[TBL] [Abstract][Full Text] [Related]
24. Partial rescreening for quality assurance in gynecological cytology.
Faraker CA
Diagn Cytopathol; 1997 Feb; 16(2):191-2. PubMed ID: 9067119
[No Abstract] [Full Text] [Related]
25. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
26. Rescreening policies in cervical cytology and their effect on detecting the truly positive patient.
Kaminsky FC; Burke RJ; Haberle KR; Mullins DL
Acta Cytol; 1995; 39(2):239-45. PubMed ID: 7887071
[TBL] [Abstract][Full Text] [Related]
27. Rapid pre-screening: a validated quality assurance measure in cervical cytology.
Smith J; Nicholas D; Boyd K; Deacon-Smith R
Cytopathology; 2003 Oct; 14(5):275-80. PubMed ID: 14510892
[TBL] [Abstract][Full Text] [Related]
28. [Cervical cancer screening. False negative smears].
Vassilakos P; De Marval F; Muñoz M
Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
[No Abstract] [Full Text] [Related]
29. Personal performance profiles: a useful adjunct to quality assurance in cervical cytology.
Houliston DC; Boyd CM; Nicholas DS; Smith JA
Cytopathology; 1998 Jun; 9(3):162-70. PubMed ID: 9638377
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
Cernescu EC; Anton G; Ruţă S; Cernescu C
Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
[TBL] [Abstract][Full Text] [Related]
32. A current appraisal of the abnormal Pap smear.
Briggs R
East Afr Med J; 1981 Jan; 58(1):18-24. PubMed ID: 7215270
[No Abstract] [Full Text] [Related]
33. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
[TBL] [Abstract][Full Text] [Related]
34. Changes to cervical screening in Australia: applying lessons learnt.
Farnsworth A
Med J Aust; 2014 Sep; 201(5):245-6. PubMed ID: 25163361
[No Abstract] [Full Text] [Related]
35. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
36. [Screening of cervical cancer, false negative vaginal smears].
Weintraub D
Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658
[No Abstract] [Full Text] [Related]
37. [Four years of screening cervical smears of cervical lesions].
Autillo-Touati A; Benmoura D; Palazzi D; Robaglia A; Tasso F; Blanc B; Seite R
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):754-60. PubMed ID: 1469229
[TBL] [Abstract][Full Text] [Related]
38. Cervical cytology screening of high-risk patients in Ondo General Hospital, Nigeria.
Sogbanmu MO
J Trop Med Hyg; 1977 May; 80(5):102-4. PubMed ID: 592451
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with the thinPrep Imager System.
Dawson AE
Acta Cytol; 2006; 50(5):481-2. PubMed ID: 17017431
[No Abstract] [Full Text] [Related]
40. Pitfalls in the screening and early diagnosis of cervical cancer.
Wain GV; Hacker NF
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
